Home
E-Submission
Sitemap
Contact Us
HOME
ABOUT
Aims and scope
About the journal
Editorial board
Open access
Contact us
BROWSE ARTICLES
Current issue
All issues
Ahead-of print
Article category
Most view
Most download
Most cited
Funded articles
Search
Author index
EDITORIAL POLICY
Ethical policies
Multiple publication or Redundant publication
Peer review process
Advertising policies
FOR CONTRIBUTORS
Instructions for authors
Author’s checklist
Copyright transfer agreement
Article-processing charge
E-submission
Search
Search
Page Path
HOME
Search
Original Articles
Haller Layer Thickness after Intravitreal Aflibercept Injection in Diabetic Macular Edema: 1 Month Change
Su Min Sung, Kyoo Won Lee, Hyun Gu Kang
J Korean Ophthalmol Soc.
2022;63(12):973-983. Published online December 15, 2022
DOI:
https://doi.org/10.3341/jkos.2022.63.12.973
Full text
PubReader
ePub
Crossref - TDM
PDF
Case Reports
A Case of Nonarteritic Anterior Ischemic Optic Neuropathy after Intravitreal Aflibercept Injection
Sungjun Joo, Joo Yeon Lee, Sung Uk Baek
J Korean Ophthalmol Soc.
2022;63(10):888-893. Published online October 14, 2022
DOI:
https://doi.org/10.3341/jkos.2022.63.10.888
Full text
PubReader
ePub
Crossref - TDM
PDF
Original Articles
Outcome of Aflibercept-Bevacizumab Alternate Dosing in Neovascular Age-related Macular Degeneration with Limited Response to Aflibercept
Daeun Shin, Jae Hui Kim
J Korean Ophthalmol Soc.
2022;63(6):526-534. Published online June 15, 2022
DOI:
https://doi.org/10.3341/jkos.2022.63.6.526
Full text
PubReader
ePub
Crossref - TDM
PDF
Association between Vortex Vein Engorgement and Treatment Outcomes of Intravitreal Aflibercept for Polypoidal Choroidal Vasculopathy
Areum Jeong, Min Sagong
J Korean Ophthalmol Soc.
2021;62(10):1370-1380. Published online October 15, 2021
DOI:
https://doi.org/10.3341/jkos.2021.62.10.1370
Full text
PubReader
ePub
Crossref - TDM
PDF
Limited Treatment Response during Follow-up after Switching to Aflibercept in Neovascular Age-related Macular Degeneration
Gon Soo Choe, Jong Woo Kim, Chul Gu Kim, Jae Hui Kim
J Korean Ophthalmol Soc.
2021;62(9):1218-1226. Published online September 15, 2021
DOI:
https://doi.org/10.3341/jkos.2021.62.9.1218
Cited By 1
Full text
PubReader
ePub
Crossref - TDM
PDF
Proportion of and Reason for Bevacizumab Usage in the Treatment of Wet Age-related Macular Degeneration
Yi Sang Yoon, Won Tae Yoon, Jong Woo Kim, Chul Gu Kim, Jae Hui Kim
J Korean Ophthalmol Soc.
2021;62(8):1076-1083. Published online August 15, 2021
DOI:
https://doi.org/10.3341/jkos.2021.62.8.1076
Full text
PubReader
ePub
Crossref - TDM
PDF
Comparison of Intravitreal Bevacizumab and Aflibercept Injections for Central Serous Chorioretinopathy
Min Soo Park, Seung Joon Lee
J Korean Ophthalmol Soc.
2021;62(7):957-962. Published online July 15, 2021
DOI:
https://doi.org/10.3341/jkos.2021.62.7.957
Full text
PubReader
ePub
Crossref - TDM
PDF
Budget Impact Analysis of Anti-vascular Endothelial Growth Factor in Patients with Diabetic Macular Edema.
Jangmi Yang, Sang Jin Shin, Jae Kyung Suh et al.
J Korean Ophthalmol Soc.
2019;60(7):667-675. Published online July 15, 2019
DOI:
https://doi.org/10.3341/jkos.2019.60.7.667
Cited By 3
PDF
Use of Anti-vascular Endothelial Growth Factors for Diabetic Retnopathy: National Health Insurance Claims Data.
Songhee Cho, Sang Jin Shin, Jae Kyung Suh et al.
J Korean Ophthalmol Soc.
2019;60(7):661-666. Published online July 15, 2019
DOI:
https://doi.org/10.3341/jkos.2019.60.7.661
Cited By 9
PDF
Analysis of Intraocular Pressure Elevation after Intravitreal Injection of Ranibizumab and Aflibercept.
Tae Kyu Moon, Jun Young Ha, Mi Sun Sung, Sang Woo Park
J Korean Ophthalmol Soc.
2019;60(4):362-368. Published online April 15, 2019
DOI:
https://doi.org/10.3341/jkos.2019.60.4.362
PDF
Meta-analysis of Intravitreal Injection of Anti-vascular Endothelial Growth Factors for Diabetic Macular Edema.
Hajin Tchoe, Sang Jin Shin, Jae Kyung Suh et al.
J Korean Ophthalmol Soc.
2019;60(2):144-151. Published online February 15, 2019
DOI:
https://doi.org/10.3341/jkos.2019.60.2.144
PDF
Clinical Changes after Switching from Ranibizumab/Aflibercept to Bevacizumab in Exudative Age-related Macular Degeneration.
In Ho Lee, Jae Jung Lee, Han Jo Kwon, Sung Who Park, Ji Eun Lee
J Korean Ophthalmol Soc.
2019;60(1):40-46. Published online January 15, 2019
DOI:
https://doi.org/10.3341/jkos.2019.60.1.40
Cited By 4
PDF
Case Reports
A Case of Choroidal Osteoma with Subretinal Hemorrhage Improved by Intravitreal Bevacizumab and Aflibercept Injections.
Charm Kim, Kyung Seek Choi, Hae Jung Sun
J Korean Ophthalmol Soc.
2018;59(10):989-994. Published online October 15, 2018
DOI:
https://doi.org/10.3341/jkos.2018.59.10.989
PDF
Rapid Progression of the Epiretinal Membrane after Intravitreal Aflibercept Injection.
Ji Min Kwon, Myung Shin Lee, Kang Yeun Pak, Hyun Woong Kim
J Korean Ophthalmol Soc.
2018;59(10):984-988. Published online October 15, 2018
DOI:
https://doi.org/10.3341/jkos.2018.59.10.984
PDF
Original Articles
Intravitreal Aflibercept Monotherapy for Treating Submacular Hemorrhage Secondary to Neovascular Age-related Macular Degeneration.
Sue Hey Chae, Soh Eun Ahn, Hee Seong Yoon
J Korean Ophthalmol Soc.
2018;59(5):437-443. Published online May 15, 2018
DOI:
https://doi.org/10.3341/jkos.2018.59.5.437
PDF
1
2
Journal of
the Korean
Ophthalmological
Society
Print ISSN: 0378-6471
Online ISSN: 2092-9374
MOST VIEWED
MOST CITED
1,579
Efficacy of Low-dose Atropine Eyedrops in Myopic Progression in Elementary School Children
963
Clinical Manifestations of Thyroid-associated Ophthalmopathy Accompanied by Thyroid Cancer
1,232
Clinical Benefits of Amniotic Membrane Contact Lens
3,104
Clinical Results of Cataract Surgery Using the ARTIS ® PL E Intraocular Lens
759
Contact Lens-induced Acute Red Eye
+more
Cited By
3
Clinical Features and Antibiotic Susceptibility of Culture-proven Infectious Keratitis: a Multicenter 10-year Study
Cited By
2
Biometric Characteristics in Eyes with Pseudoexfoliation Syndrome and Eyes with Acute Angle Closure
Cited By
2
The Status of Infectious Keratitis in Gwang-ju, Jeonnam, Republic of Korea
Cited By
2
Changes in Incidences of Chronic and Traumatic Diseases before and after Registration as Visually Disabled
Cited By
2
Short-term Outcomes and Prognostic Factors of Cataract-combined Surgery with iStent versus iStent Inject
+more
ABOUT
Aims and scope
About the journal
Editorial board
Open access
Contact us
BROWSE ARTICLES
Current issue
All issues
Ahead-of print
Article category
Most view
Most download
Most cited
Funded articles
Search
Author index
EDITORIAL POLICY
Ethical policies
Multiple publication or Redundant publication
Peer review process
Advertising policies
FOR CONTRIBUTORS
Instructions for authors
Author’s checklist
Copyright transfer agreement
Article-processing charge
E-submission